Pharmacoeconomic review report Tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto respimat) for oral inhalation
Inspiolto Respimat (tiotropium bromide monohydrate/olodaterol hydrochloride [TIO/OLO]) is a fixeddose combination of a long-acting muscarinic antagonist (LAMA), tiotropium, and a long-acting beta2 agonist (LABA), olodaterol, indicated for the long-term, once-daily maintenance bronchodilator treatmen...
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Ottawa (ON) :
Canadian Agency for Drugs and Technologies in Health
2015.
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820267306719 |
| Sumario: | Inspiolto Respimat (tiotropium bromide monohydrate/olodaterol hydrochloride [TIO/OLO]) is a fixeddose combination of a long-acting muscarinic antagonist (LAMA), tiotropium, and a long-acting beta2 agonist (LABA), olodaterol, indicated for the long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. TIO/OLO is available as a multi-use cartridge to be used with the Respimat device, which provides 2.5 mcg of TIO and 2.5 mcg of OLO per actuation. The recommended dose of TIO/OLO is two actuations once daily. |
|---|---|
| Descripción Física: | 1 online resource (11 pages) |
